1 / 27

Prostate Cancer Screening in African American Men

Prostate Cancer Screening in African American Men. Mark H. Kawachi, MD FACS Director, Prostate Cancer Center City of Hope, National Medical Ctr. Prostate Cancer Early Detection. The National Comprehensive Cancer Network (NCCN) is an alliance of 21 of the world’s leading cancer centers.

edric
Download Presentation

Prostate Cancer Screening in African American Men

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Prostate Cancer Screening in African American Men Mark H. Kawachi, MD FACS Director, Prostate Cancer Center City of Hope, National Medical Ctr

  2. Prostate Cancer Early Detection • The National Comprehensive Cancer Network (NCCN) is an alliance of 21 of the world’s leading cancer centers. • NCCN guidelines are widely recognized by oncology clinicians and payors. • Where possible, the cancer guidelines are evidence-based.

  3. Definition of “Screening” • No universally accepted definition. • Generally thought of as a method of applying a test to an at-risk population to determine the presence or absence of a particular disease. • Utilizing this (or similar definition) ignores or discounts the individual’s ability to participate in the decision making process.

  4. Prostate Cancer Early Detection • The prostate cancer early detection guidelines stress the importance of involving the patient and informing him of the implications and potential consequences that may arise from the decision to embark on an early detection pathway. • As such the pro’s and con’s of the early detection algorithm are thoroughly discussed.

  5. Overview of AA Cancer Dilemma in the USA • The age adjusted cancer related mortality in the USA is 1.4 times higher for black men than for white men. • The disparity is greatest for prostate cancer, for which incidence rates are 1.7 times and mortality rates 2.4 times higher for black men.

  6. Overview of AA Cancer Dilemma in the USA • In the Medicare pt population, this is further quantified with a 1.8-year shorter survival for black men with localized CaP treated with surgery, 0.7 years shorter after radiation therapy, and 1.0 years shorter for watchful waiting. These findings persist even after accounting for covariates including education and income levels.

  7. What’s the Difference • Genetic predisposition? • Differences in tumor initiation, promotion, and progression? • Differences in higher fat diets, higher testosterone exposure/levels, or higher BMI? • Structural, financial, and cultural differences to screening, early detection, or aggressive therapy? • Physician bias?

  8. There May Be Reason for Optimism in the USA • There is data, that now suggests that in the PSA era, that the organ confined disease rate is increasing, and that the disparity in the mortality is lessening. • It would also appears that stage for stage the same high cure rates can be achieved in black men as in their white counterparts

  9. Family Hx and CaP Risk Bostwick, Cancer 2004:101(10Sup):2371 Bratt J Uro 2002; 168:906 Morganti,Acta Genet Stat Med 1956-1957; 6(2):304

  10. AA CaP Incidence USNIH SEER data accessed 2008

  11. AA CaP Mortality By Age Powell, J Urol 171,1508,2004

  12. AA Mortality: Organ Confined vs Non-Organ Confined Powell, J Urol 171,1508,2004

  13. AA Recurrence: Before and After 1996 Bianco, J Urol, 168, 479, 2002

  14. AA CaP Recurrence By Dates Bianco, J Urol, 168, 479, 2002

  15. AA CaP Recurrence By Dates Catalona, J Urol, 168, 1980, 2002

  16. AA CaP Recurrence By Dates Catalona, J Urol, 168, 1980, 2002

  17. Impact of Race on CaP Outcomes Cross, JCO, 20, No12, 2002, 2863

  18. Summary • At present the evidence does not suggest that the biology of prostate cancer in black men differs from that of any other group in any identifiable or clinically meaningful way. • In fact, recent data suggests similar cure rates for organ confined disease. • Therefore, the data would imply that race should not influence the decision on the need for initial or subsequent prostate biopsy or the decision for or choice of therapy for any stage of prostate cancer.

  19. Conclusion • It is intuitive to think that early detection of prostate cancer will lead to earlier and more effective therapies; however there is limited evidence to support this statement. • For men who choose to be screened by digital rectal examination and PSA, those in the highest risk groups (AA/family history) should begin at a younger age (eg 40 years) than those of average risk.

  20. Conclusion • Despite the absence of known biological differences or firm evidence of a beneficial effect of screening on mortality, these recommendations seem prudent in the face of the higher age adjusted incidence and historical mortality rates for organ confined cancers in AA men in the USA.

  21. Conclusion • Future studies to help clarify the relationship between histologic and clinically evident prostate cancer and the true effect of PSA screening on prostate cancer mortality are necessary.

More Related